eMAPS 3 targets entrepreneurs, innovators, SMEs and others in the life science sector. Gives entrepreneurs and SMEs access to practical knowledge that can be applied to gain market access, allowing them to bring products to market in a sustainable and cost-effective way. Through this platform aims to accelerate innovation adoption to improve the health of European citizens. eMAPS 3 covers the area of the drugs and biotech products; medical devices and diagnostics; and digital health solutions.
The eMAPs platform is an innovative learning portal to support entrepreneurs and innovators to navigate the complex processes and pathways involved in accessing healthcare markets (drugs and biotech products; medical devices and diagnostics; and digital health solutions) across Europe. The eMAPS 3 proposal will further develop the platform by adding much needed information on Germany, Italy and Portugal as well as the US.